217 related articles for article (PubMed ID: 3227479)
1. [Anti-aggregation therapy of patients with ischemic heart disease].
Liusov VA; Savenkov MP
Ter Arkh; 1988; 60(8):55-9. PubMed ID: 3227479
[No Abstract] [Full Text] [Related]
2. [Effect of ticlopidine and dipyridamole on platelet aggregation and count in patients with chronic stable angina pectoris].
Ramires JA; Mansur Ade P; Martins JR; Raineri A; Cesar LA; Bellotti G; Chamone DF; Pileggi F
Arq Bras Cardiol; 1991 Apr; 56(4):323-7. PubMed ID: 1888308
[TBL] [Abstract][Full Text] [Related]
3. Platelet function inhibitors: their clinical use.
Fuster V; Didisheim P
Adv Intern Med; 1978; 23():251-64. PubMed ID: 343540
[No Abstract] [Full Text] [Related]
4. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
[TBL] [Abstract][Full Text] [Related]
5. [Platelet antiaggregants and arteriopathies].
Cristol R
J Mal Vasc; 1981; 6(3):237-41. PubMed ID: 7026714
[No Abstract] [Full Text] [Related]
6. Antiplatelet therapy.
Sloan RW
Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
[TBL] [Abstract][Full Text] [Related]
7. Variability in platelet aggregation following sustained aspirin and clopidogrel treatment in patients with coronary heart disease and influence of the 807 C/T polymorphism of the glycoprotein Ia gene.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Cavallari U; Trabetti E; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Pignatti PF; Macaya C
Am J Cardiol; 2005 Oct; 96(8):1095-9. PubMed ID: 16214444
[TBL] [Abstract][Full Text] [Related]
8. [Prophylactic value of platelet anti-aggregants in coronary disease].
Verstraete M
Clin Ter; 1979 Oct; 91(2):117-27. PubMed ID: 396098
[No Abstract] [Full Text] [Related]
9. [Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Shalaev SV
Kardiologiia; 1989 Sep; 29(9):116-20. PubMed ID: 2687554
[No Abstract] [Full Text] [Related]
10. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry.
Bauriedel G; Skowasch D; Schneider M; Andrié R; Jabs A; Lüderitz B
Am Heart J; 2003 Feb; 145(2):343-8. PubMed ID: 12595854
[TBL] [Abstract][Full Text] [Related]
11. [Antiplatelet drugs and prevention of aortocoronary bypass occlusion].
Davì G; Botindari G; Catalano I; Strano A
Cardiologia; 1988 Feb; 33(2):123-6. PubMed ID: 3282656
[No Abstract] [Full Text] [Related]
12. [Treatment of ischemic heart disease with the platelet aggregation inhibitor clopidogrel].
Helø OH; Madsen JK; Kastrup J
Ugeskr Laeger; 2004 Apr; 166(18):1659-62. PubMed ID: 15174400
[No Abstract] [Full Text] [Related]
13. Aspirin and other platelet-aggregation inhibiting drugs.
Gallus AS
Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
[TBL] [Abstract][Full Text] [Related]
14. Status of antiplatelet drugs in coronary heart disease.
Mehta J; Mehta P
JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365
[No Abstract] [Full Text] [Related]
15. [Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
Croveri G
Minerva Cardioangiol; 1980 Oct; 28(10):723-6. PubMed ID: 7465066
[No Abstract] [Full Text] [Related]
16. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
[TBL] [Abstract][Full Text] [Related]
17. [Current clinical results of antiplatelet medication].
Ordinas A
Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
[No Abstract] [Full Text] [Related]
18. [Evaluation of antithrombin III activity in ischemic cardiopathy: changes due to treatment with platelet anti-aggregants].
Avellone G; Mandalà V; Novo S; Davì G; Pinto A; Riolo FP
Boll Soc Ital Cardiol; 1979; 24(11):1229-33. PubMed ID: 261907
[No Abstract] [Full Text] [Related]
19. [Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
Verstraete M
Recenti Prog Med; 1980 Apr; 68(4):361-81. PubMed ID: 6992244
[No Abstract] [Full Text] [Related]
20. [Antiplatelet agents (inhibitors of platelet function) orally administered. Bases for their practical use in coronary artery disease].
Lecompte T; de Maistre E
Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1507-13. PubMed ID: 9092411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
